(Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 35.64%-506.47M | ---- | -334.61%-786.94M | ---- | 18.68%-181.07M | ---- | 41.86%-222.65M | ---- | -142.32%-382.93M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 99.11%-241K | ---- | 10.65%-27.02M | ---- | 7.39%-30.24M | ---- | -6.95%-32.66M | ---- | -1.30%-30.54M |
Interest expense - adjustment | ---- | 1.92%247.15M | ---- | 15.69%242.5M | ---- | -18.85%209.62M | ---- | -20.41%258.32M | ---- | 0.74%324.55M |
Attributable subsidiary (profit) loss | ---- | 12,370.00%1.23M | ---- | 44.44%-10K | ---- | 28.00%-18K | ---- | -114.04%-25K | ---- | -57.42%178K |
Impairment and provisions: | --0 | 261.72%409.64M | --0 | --113.25M | --0 | --0 | --0 | --0 | --0 | 64.39%84.98M |
-Impairment of property, plant and equipment (reversal) | ---- | --220.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | --4.84M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -15.97%39.24M |
-Other impairments and provisions | ---- | 62.85%184.43M | ---- | --113.25M | ---- | ---- | ---- | ---- | ---- | 816.70%45.73M |
Revaluation surplus: | --0 | 124.59%1.58M | --0 | 59.56%-6.43M | --0 | -279.91%-15.89M | --0 | 113.23%8.83M | --0 | 71.01%-66.77M |
-Other fair value changes | ---- | 124.59%1.58M | ---- | 59.56%-6.43M | ---- | -279.91%-15.89M | ---- | 113.23%8.83M | ---- | 71.01%-66.77M |
Asset sale loss (gain): | --0 | -98.76%1.85M | --0 | --149.18M | --0 | --0 | --0 | --0 | --0 | -103.21%-59K |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -110.71%-59K |
-Loss (gain) from selling other assets | ---- | -98.76%1.85M | ---- | --149.18M | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | --0 | 17.09%91.38M | --0 | 48.85%78.04M | --0 | -13.43%52.43M | --0 | 4.39%60.56M | --0 | -21.25%58.01M |
-Depreciation | ---- | 13.89%64.76M | ---- | 56.08%56.86M | ---- | -14.05%36.43M | ---- | 23.20%42.38M | ---- | -35.32%34.4M |
-Amortization of intangible assets | ---- | 29.45%31.29M | ---- | 35.04%24.17M | ---- | -10.95%17.9M | ---- | -14.01%20.1M | ---- | 15.42%23.37M |
-Other depreciation and amortization | ---- | -55.99%-4.66M | ---- | -57.20%-2.99M | ---- | 0.99%-1.9M | ---- | -900.42%-1.92M | ---- | 3.00%240K |
Special items | ---- | -102.35%-8.25M | ---- | 2,967.34%351.67M | ---- | 138.95%11.47M | ---- | -84.97%4.8M | ---- | 91,134.29%31.93M |
Operating profit before the change of operating capital | --0 | 108.22%237.86M | --0 | 146.81%114.24M | --0 | -40.03%46.29M | --0 | 298.67%77.18M | --0 | -38.24%19.36M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 35.00%-1.73M | ---- | -1,274.34%-2.65M | ---- | -87.52%226K | ---- | -27.21%1.81M | ---- | 170.38%2.49M |
Accounts receivable (increase)decrease | ---- | -63.56%18.47M | ---- | 328.84%50.69M | ---- | 57.10%-22.15M | ---- | -156.46%-51.64M | ---- | 29.58%91.46M |
Accounts payable increase (decrease) | ---- | -155.10%-9.26M | ---- | -64.65%16.81M | ---- | 149.72%47.56M | ---- | 118.90%19.05M | ---- | ---100.75M |
Cash from business operations | --0 | 36.77%244.8M | --0 | 120.61%178.99M | --0 | 124.41%81.13M | --0 | 187.92%36.15M | --0 | -89.94%12.56M |
China income tax paid | ---- | -80.37%-1.93M | ---- | 53.05%-1.07M | ---- | 43.94%-2.28M | ---- | 13.33%-4.07M | ---- | -5.92%-4.69M |
Special items of business | ---- | -422.12%-543K | ---- | -101.13%-104K | ---- | 189.94%9.21M | ---- | ---10.24M | ---- | ---- |
Net cash from operations | -18.84%44.1M | 36.51%242.87M | -6.88%54.34M | 125.63%177.92M | 2.43%58.35M | 145.74%78.86M | 50.25%56.96M | 307.89%32.09M | 1,371.21%37.91M | -93.46%7.87M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -86.54%241K | ---- | 54.26%1.79M | ---- | 4,365.38%1.16M | ---- | -36.59%26K | ---- | -99.20%41K |
Loan receivable (increase) decrease | ---- | 187.62%9.19M | ---- | -91.84%-10.49M | ---- | 87.18%-5.47M | ---- | -227.34%-42.65M | ---- | 172.62%33.49M |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -7.91%198K |
Purchase of fixed assets | ---- | -2.94%-208.02M | ---- | 29.77%-202.09M | ---- | -289.82%-287.77M | ---- | -39.73%-73.82M | ---- | 60.28%-52.83M |
Purchase of intangible assets | ---- | ---- | ---- | 58.37%-535K | ---- | 79.97%-1.29M | ---- | 9.55%-6.42M | ---- | 32.80%-7.09M |
Recovery of cash from investments | ---- | -88.88%6.2M | ---- | --55.77M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | ---8.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | 36.58%62.51M | ---- | -58.44%45.77M | ---- | -29.04%110.12M | ---- | 995.24%155.18M | ---- | -5.34%14.17M |
Net cash from investment operations | 56.11%-37.5M | -26.02%-138.35M | -1,899.44%-85.44M | 40.09%-109.78M | 96.42%-4.27M | -666.90%-183.24M | -1,360.01%-119.32M | 368.82%32.32M | 848.62%9.47M | 93.09%-12.02M |
Net cash before financing | 121.22%6.6M | 53.41%104.53M | -157.51%-31.1M | 165.27%68.14M | 186.72%54.08M | -262.06%-104.38M | -231.61%-62.36M | 1,649.48%64.41M | 3,511.51%47.38M | 92.25%-4.16M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 294.20%374.79M | ---- | -68.18%95.08M | ---- | 363.55%298.76M | ---- | 26.50%64.45M | ---- | -68.15%50.95M |
Refund | ---- | -191.60%-317.93M | ---- | -148.09%-109.03M | ---- | -303.08%-43.95M | ---- | 92.18%-10.9M | ---- | -75.08%-139.47M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --535.49M |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -95.53%6M |
Interest paid - financing | ---- | 17.75%-48.47M | ---- | -20.43%-58.93M | ---- | 45.58%-48.93M | ---- | 18.33%-89.91M | ---- | 14.50%-110.08M |
Issuance expenses and redemption of securities expenses | ---- | 96.52%-505K | ---- | -88.31%-14.5M | ---- | 64.02%-7.7M | ---- | 93.08%-21.4M | ---- | -16.56%-309.14M |
Other items of the financing business | ---- | 15.21%-5.94M | ---- | -52.43%-7.01M | ---- | 19.11%-4.6M | ---- | ---5.68M | ---- | ---- |
Net cash from financing operations | -274.87%-57.76M | 102.06%1.95M | 186.77%33.03M | -148.76%-94.39M | -121.36%-38.07M | 405.12%193.58M | 383.05%178.19M | -287.95%-63.44M | -268.41%-62.96M | 118.82%33.76M |
Effect of rate | 22.42%39.03M | -101.05%-41.91M | 497.06%31.88M | 34.92%-20.85M | -2,181.25%-8.03M | 6.31%-32.03M | 93.08%-352K | -137.18%-34.19M | -86.45%-5.09M | -547.12%-14.42M |
Net Cash | -2,748.19%-51.16M | 505.56%106.47M | -87.93%1.93M | -129.43%-26.25M | -86.18%16.01M | 9,114.88%89.2M | 843.84%115.83M | -96.73%968K | -140.25%-15.57M | 112.70%29.6M |
Begining period cash | 467.86%78.36M | -77.34%13.8M | -77.34%13.8M | 1,533.53%60.9M | 1,533.53%60.9M | -89.91%3.73M | -89.91%3.73M | 69.76%36.95M | 69.76%36.95M | -91.35%21.77M |
Cash at the end | 39.10%66.23M | 467.86%78.36M | -30.87%47.62M | -77.34%13.8M | -42.22%68.88M | 1,533.53%60.9M | 631.92%119.21M | -89.91%3.73M | -71.79%16.29M | 69.76%36.95M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data